A detailed history of Ameritas Investment Partners, Inc. transactions in Poseida Therapeutics, Inc. stock. As of the latest transaction made, Ameritas Investment Partners, Inc. holds 5,612 shares of PSTX stock, worth $53,314. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,612
Previous 5,612 -0.0%
Holding current value
$53,314
Previous $16,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

BUY
$1.66 - $3.4 $9,315 - $19,080
5,612 New
5,612 $9,000
Q2 2022

Aug 12, 2022

SELL
$1.87 - $5.0 $5,035 - $13,465
-2,693 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$8.51 - $11.91 $13,181 - $18,448
1,549 Added 135.4%
2,693 $26,000
Q3 2020

Nov 13, 2020

BUY
$8.09 - $16.25 $9,254 - $18,590
1,144 New
1,144 $10,000

Others Institutions Holding PSTX

About Poseida Therapeutics, Inc.


  • Ticker PSTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 85,775,600
  • Market Cap $815M
  • Description
  • Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for patients with high unmet medical needs. The company develops P-PSMA-101, an autologous chimeric antigen receptor T cell (CAR-T) product candidate that is in Phase I trial for the treatment of patients with metastatic castrate resistant ...
More about PSTX
Track This Portfolio

Track Ameritas Investment Partners, Inc. Portfolio

Follow Ameritas Investment Partners, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.